✦ LIBER ✦

Establishing a Platform for Immunotherapy: Clinical Outcome and Study of Immune Reconstitution after High-Dose Chemotherapy with Progenitor Cell Support in Breast Cancer Patients

✍ Scribed by Claude Sportès; Nicole J. McCarthy; Frances Hakim; Seth M. Steinberg; David J. Liewehr; David Weng; Shivaani Kummar; Juan Gea-Banacloche; Catherine K. Chow; Robert M. Dean; Kathleen M. Castro; Donna Marchigiani; Michael R. Bishop; Daniel H. Fowler; Ronald E. Gress

Book ID: 116278317
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 329 KB
Volume: 11
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.03.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Capecitabine as First-Line Therap

Use of Capecitabine as First-Line Therapy in Patients with Metastatic Breast Cancer Relapsing After High- Dose Chemotherapy and Autologous Stem Cell Support

✍ A. Bashey; S. Sundaram; S. Corringham; V. Jones; D. Lancaster; J. Silva-Gietzen; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Prognostic significance of occult tumor

Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support

✍ Yago Nieto; Wilbur A Franklin; Roy B Jones; Scott I Berman; Julie Pellom; Anna E 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Isolation and transplantation of highly

Isolation and transplantation of highly purified autologous peripheral CD34+progenitor cells: purging efficacy, hematopoietic reconstitution following high dose chemotherapy in patients with breast cancer: results of a feasibility study in Japan

✍ Takaaki Chou; Muneaki Sano; Michinori Ogura; Yasuo Morishima; Hiroyuki Itagaki; 📂 Article 📅 2005 🏛 Springer Japan 🌐 English ⚖ 993 KB

High-dose chemotherapy and stem cell tra

High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome

✍ Ahmed, T; Kancherla, R; Qureshi, Z; Mittelman, A; Seiter, K; Mannancheril, A; Pu 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

A phase II study of two cycles of high-d

A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle

✍ Bashey, A; Corringham, S; Garrett, J; Lane, T A; Gilpin, E A; Corringham, R E T; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Randomized trial of peripheral blood pro

Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin’s lymphoma and Hodgkin’s disease: a clinical and molecular analysis

✍ Kanteti, R; Miller, K B; McCann, J C; Roitman, D; Morelli, J; Hurley, C; Berkman 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB